Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection

Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009

(2014) Anne F. Rositch et al.   CANCER

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2

(2014) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States

(2013) Jane J. Kim   ANNALS OF INTERNAL MEDICINE

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

(2013) Hormuzd A. Katki et al.   Journal of Lower Genital Tract Disease

Contributions of Recent and Past Sexual Partnerships on Incident Human Papillomavirus Detection: Acquisition and Reactivation in Older Women

(2012) A. F. Rositch et al.   CANCER RESEARCH

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

(2012) Debbie Saslow et al.   Journal of Lower Genital Tract Disease

The Correlation Between Human Papillomavirus Positivity and Abnormal Cervical Cytology Result Differs by Age Among Perimenopausal Women

(2012) Anne F. Rositch et al.   Journal of Lower Genital Tract Disease

Time since first sexual intercourse and the risk of cervical cancer

(2011) Martyn Plummer et al.   INTERNATIONAL JOURNAL OF CANCER

The known unknowns of HPV natural history

(2011) Patti E. Gravitt   JOURNAL OF CLINICAL INVESTIGATION

Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer

(2011) H.-C. Chen et al.   JNCI-Journal of the National Cancer Institute

Human Papillomavirus Testing in the Prevention of Cervical Cancer

(2011) Mark Schiffman et al.   JNCI-Journal of the National Cancer Institute

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

(2011) Hormuzd A Katki et al.   LANCET ONCOLOGY

Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years

(2010) P. Gonzalez et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

(2010) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Rate of and Risks for Regression of Cervical Intraepithelial Neoplasia 2 in Adolescents and Young Women

(2010) Anna-Barbara Moscicki et al.   OBSTETRICS AND GYNECOLOGY

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women

(2009) N Muñoz et al.   BRITISH JOURNAL OF CANCER

Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology

(2009) Delphine Maucort-Boulch et al.   INTERNATIONAL JOURNAL OF CANCER

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study

(2008) Marc T. Goodman et al.   CANCER RESEARCH